News

CI is expanding AI across care coordination and specialty pharmacy as it seeks to manage elevated healthcare costs and improve access.

CNC's profitability is recovering, but rising margins face a key test as Medicaid membership declines and eligibility reviews continue.

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

When the Federal Reserve lifts rates and signals they may stay elevated for years, the easy-growth playbook breaks. Cash flows today matter more than promises tomorrow, and investors start to care a lot about balance sheet strength, pricing power and dependable dividends. This article walks through three large cap quality defensive stocks that screen well under those rules and explains how the latest Fed move could affect each one. The three stocks below are a sample of what this quality...

UnitedHealth is staging a turnaround after raising full-year adjusted EPS guidance. The firm also pays an annualized dividend of $9.28 with a yield above 2.4%.

UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.

Healthcare stocks Eli Lilly, UnitedHealth Group, and Johnson & Johnson offer options for investors of different ages, combining growth potential, turnaround momentum, and reliable dividends.

Auxier Asset Management, an investment advisory firm, released its second-quarter 2026 investor letter. The letter can be downloaded here. Following a strong rebound from the first-quarter decline, the S&P 500 gained 15.2% as accelerating capital spending toward artificial intelligence infrastructure drove significant gains across technology hardware companies. Semiconductor and data-center-related businesses benefited from supply constraints […]

Walmart, UnitedHealth and Wells Fargo highlight resilient growth, while XMax and Interlink pursue expansion despite execution challenges.

UnitedHealth, Dell and Goldman Sachs headline a week of rate decisions, rising commodity inflation and global political uncertainty.

CVS Health's Health Services arm is gaining from pharmacy strength and improving care delivery, with robust new sales and clinic economics supporting growth.

The health care giant showered its owners with cash, yet the stock spent years in the slow lane. Here’s the accounting of what that trade-off actually delivered.

Walmart's omnichannel strength, UnitedHealth's raised 2026 EPS outlook and Wells Fargo's asset-cap removal highlight today's reports.

Optum Health hit a wall due to rising costs and restrictive Medicare Advantage payments.

THC's shares are gaining on higher-acuity demand, strong commercial revenues and USPI's continued expansion.

UnitedHealth (UNH) has been facing investor questions surrounding the upcoming release of Medicare A

UnitedHealth Group Inc (NYSE:UNH) recently announced a total dividend of $2.32 per share, with the ex-dividend date set for 2026-09-14. This amount consists of $2.32 per share in cash dividends, payable on 2026-09-22. Investors should note that the ex-dividend date of 2026-09-14 means shareholders must own the stock before that date to qualify for the payment.

A static dividend yield quietly loses ground every month inflation climbs, but five companies have been raising their payouts fast enough to fight back. The question is which ones have the cash flow to keep doing it.

UnitedHealth is removing prior-authorization hurdles for 1,700 services. Less paperwork sounds great, but what does it mean for UNH investors?

Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

CNC is set to reshape its Medicare Advantage business around dual-eligible members and a simpler footprint to drive margin recovery.

UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.

CVS is benefiting from pharmacy growth, AI investments and a discounted valuation, but reimbursement pressure and regulatory scrutiny remain key risks.

CVS Health (NYSE:CVS) executives said the company is seeing improved momentum across its insurance, pharmacy, care delivery and balance-sheet priorities, while maintaining a cautious outlook on healthcare cost trends and several 2027 headwinds. Speaking at an investor conference, Chief Financial Of

UnitedHealth Group (NYSE:UNH) executives said the company’s turnaround remained on track, citing continued strength in Medicare Advantage, Medicaid performance that is tracking toward the favorable end of expectations, and operational improvements at Optum Health. Speaking at an investor conference

UnitedHealth Group Incorporated’s (NYSE:UNH) insurance unit is removing prior-authorization requirements from a broad range of healthcare services beginning October 1. The changes form part of UnitedHealthcare’s plan to eliminate such requirements for 30% of healthcare services by the end of 2026. The initiative could reduce administrative work for patients, providers, and the insurer itself while […]

The latest trading day saw UnitedHealth Group (UNH) settling at $393.06, representing a -1.94% change from its previous close.

Healthcare stocks were lower late Wednesday afternoon with the NYSE Healthcare Index and the State S

UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.

On September 3, a caller asked if UnitedHealth Group Incorporated (NYSE:UNH) has enough profitable growth that they should consider adding it to their portfolio. Mad Money host Jim Cramer replied: Yes, the answer: it does, it does. You know, I’ve got to tell you, I thought that last quarter was very, very good. The stock […]